Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma

Elizabeth Belcher, Timothy Hardwick, Rohit Lal, Stuart Marshall, James Spicer, Loic Lang-Lazdunski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

The optimal treatment for Masaoka stage IVA thymoma remains controversial. Whilst extrapleural pneumonectomy (EPP) has been proposed, we sought to examine the results of our institutional preference for induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation. We undertook a retrospective study of patients undergoing surgery for Masaoka stage IVA thymoma following induction chemotherapy over a three-year period at our institution. Between February 2007 and February 2010, 42 patients underwent surgery for thymoma. Six patients underwent surgery with intent to perform cytoreductive surgery and intraoperative hyperthermic pleural irrigation. Complete cytoreductive surgery was not feasible in one patient and thymectomy only was performed. One patient had re-operation for recurrent disease 24 months after the first operation and there were therefore seven procedures undertaken in six patients during the study period. There were no in-hospital deaths. Median follow-up was 18.8 months (range 1.5-31.9 months). One patient died 14 months postoperatively from an acute cardiovascular event. The four remaining patients are alive and well with no evidence of disease recurrence. Multimodality therapy consisting of induction chemotherapy and cytoreductive surgery is a safe, feasible treatment for stage IVA thymoma. Our experience suggest that full pleurectomy is an alternative to EPP. (C) 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.

Original languageEnglish
Pages (from-to)744-746
Number of pages3
JournalInteractive Cardiovascular & Thoracic Surgery
Volume12
Issue number5
DOIs
Publication statusPublished - May 2011
Event24th Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery (EACTS) - Geneva, Switzerland
Duration: 11 Sept 201015 Sept 2010

Keywords

  • Thymoma
  • Multimodality therapy
  • SURGICAL RESECTION
  • MESOTHELIOMA
  • FEASIBILITY
  • PERFUSION
  • THERAPY

Fingerprint

Dive into the research topics of 'Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma'. Together they form a unique fingerprint.

Cite this